Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Imatinib-induced purpuric vasculitis].

M Hamm1, J P Touraud, L Mannone

  • 1Service de Dermatologie, Hôpital du Bocage, Dijon.

Annales De Dermatologie Et De Venereologie
|October 25, 2003
PubMed
Summary

Imatinib (Glivec) can cause purpuric vasculitis, a rare skin reaction. This case highlights the importance of recognizing and managing cutaneous adverse effects during chronic myeloid leukemia treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Instruments to assess appropriateness of hip and knee arthroplasty: a systematic review.

Osteoarthritis and cartilage·2023
Same author

Mid-infrared emissivity of partially dehydrated asteroid (162173) Ryugu shows strong signs of aqueous alteration.

Nature communications·2022
Same author

The Global Task Force for Chronic Pain in People with HIV (PWH): Developing a research agenda in an emerging field.

AIDS care·2021
Same author

Pre-exposure prophylaxis for HIV infection and new sexually transmitted infections among men who have sex with men: real-life experience from three sexual health clinics in France.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

[Uveitis and tattoos].

Bulletin de l'Academie nationale de medecine·2020
Same author

[Penile malakoplakia associated with lichen sclerosus].

Annales de dermatologie et de venereologie·2019

Area of Science:

  • Oncology
  • Dermatology
  • Pharmacology

Background:

  • Imatinib (Glivec) is a tyrosine-kinase inhibitor used for chronic myeloid leukemia (CML).
  • Cutaneous side effects are common during imatinib therapy.
  • This study reports a rare case of purpuric vasculitis potentially linked to imatinib.

Observation:

  • A 65-year-old male with CML developed a rash after two months of imatinib treatment.
  • The rash resolved upon drug discontinuation but recurred upon reintroduction.
  • A painful, purpuric eruption on the legs was observed, confirmed as vasculitis via biopsy.

Findings:

  • The patient presented with purpuric vasculitis, a previously unreported adverse cutaneous reaction to imatinib.
  • Histological examination confirmed vasculitis consistent with a drug-induced reaction (toxiderma).

Related Experiment Videos

  • Treatment with oral corticosteroids led to the resolution of the vasculitic lesions.

    • Implications:

    • This case suggests a potential causal link between imatinib and purpuric vasculitis.
    • Early recognition and management of cutaneous reactions are crucial in patients receiving imatinib.
    • Further research is needed to elucidate the physiopathological mechanisms of imatinib-induced skin reactions.